Senior insider sale
Chief Executive Officer at LEGEND BIOTECH CORP — senior position signals high conviction
$1.55M
40.58K shares
What this filing means
HUANG YING plans to sell 40.58K shares of LEGEND BIOTECH CORP valued at approximately $1.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/23/2025ACC: 0001959173-25-006168
DirectorOfficer· Chief Executive Officer
Since Mar 2026
40.58K
Shares to sell
$1.55M
Approx. market value
1.36K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
9/19/2025
1.36KTotal acquired1.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/19/2025 | Restricted Stock Vesting Compensation | 1.36K | — |
| Total | 1.36K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
15.29K
Market value
$688.7K
7/23/2025
—Completed
Units to sell
12.12K
Market value
$408.7K
6/25/2025
—Completed
Units to sell
11.81K
Market value
$408.6K
6/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.36K
Market value
$46.1K
9/23/2025
Total
Units
40.58K
Value
$1.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/23/2025 | 15.29K | $688.7K | — | Completed |
6/25/2025 | 12.12K | $408.7K | — | Completed |
6/24/2025 | 11.81K | $408.6K | — | Completed |
| Planned — Approximate Date | ||||
9/23/2025 | 1.36K | $46.1K | NASDAQ | Planned |
| Total | 40.58K | $1.55M | ||